搜尋





搜尋





市場行情
/
股票
/
stro
/

Sutro Biopharma Inc

STRO

添加自選

24.170USD

-0.650-2.62%

收盤 07-31 16:00（美東）報價延遲15分鐘

400.51M總市值

虧損本益比TTM

Sutro Biopharma Inc

24.170

-0.650-2.62%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

STRO 利潤表

您可以在這裡找到Sutro Biopharma Inc的年度或季度收入報告，以深入了解Sutro Biopharma Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q1

FY2017Q4

FY2017Q3

營業總收入

-16.53%14.52M

-21.35%11.65M

13.77%9.69M

147.98%63.74M

33.76%17.40M

-86.98%14.81M

-49.66%8.52M

146.89%25.71M

2.64%13.01M

1217.44%113.72M

-32.70%16.92M

-62.94%10.41M

114.92%12.67M

-18.98%8.63M

195.26%25.15M

0.17%28.10M

-59.77%5.90M

28.70%10.65M

-52.21%8.52M

196.22%28.05M

104.98%14.66M

-26.78%8.28M

45.17%17.82M

-10.03%9.47M

-17.12%7.15M

-40.77%11.30M

56.67%12.28M

--10.53M

48.96%8.63M

372.43%19.09M

-55.22%7.84M

--5.79M

--4.04M

--17.50M

營業收入

-16.53%14.52M

-21.35%11.65M

13.77%9.69M

147.98%63.74M

33.76%17.40M

-86.98%14.81M

-49.66%8.52M

146.89%25.71M

2.64%13.01M

1217.44%113.72M

-32.70%16.92M

-62.94%10.41M

114.92%12.67M

-18.98%8.63M

195.26%25.15M

0.17%28.10M

-59.77%5.90M

28.70%10.65M

-52.21%8.52M

196.22%28.05M

104.98%14.66M

-26.78%8.28M

--17.82M

-10.03%9.47M

-17.12%7.15M

-38.67%11.30M

----

--10.53M

48.96%8.63M

356.24%18.43M

-60.43%6.92M

--5.79M

--4.04M

--17.50M

營業費用

-31.96%44.14M

-43.42%45.30M

-36.43%48.59M

-34.58%48.67M

-6.79%64.87M

13.46%80.07M

25.44%76.44M

31.45%74.39M

26.75%69.60M

21.98%70.57M

31.45%60.94M

19.20%56.59M

21.95%54.91M

26.62%57.85M

7.33%46.36M

25.42%47.48M

33.74%45.03M

37.95%45.69M

51.87%43.19M

46.23%37.85M

27.86%33.67M

26.96%33.12M

13.71%28.44M

6.92%25.89M

15.01%26.33M

16.66%26.09M

39.01%25.01M

--24.21M

30.86%22.89M

16.42%22.36M

-3.08%17.99M

--17.50M

--19.21M

--18.56M

研發費用

-29.16%36.55M

-48.42%36.64M

-35.83%39.85M

-38.21%38.33M

-9.28%51.60M

32.12%71.04M

36.00%62.11M

49.12%62.02M

44.36%56.88M

24.64%53.77M

44.00%45.67M

28.64%41.59M

31.37%39.40M

44.13%43.13M

19.22%31.71M

27.75%32.33M

32.92%29.99M

31.62%29.93M

37.40%26.60M

46.78%25.31M

28.05%22.56M

30.74%22.74M

14.58%19.36M

6.81%17.24M

16.07%17.62M

17.62%17.39M

33.66%16.90M

--16.14M

16.04%15.18M

-2.33%14.79M

-7.51%12.64M

--13.08M

--15.14M

--13.67M

折舊攤銷及損耗

-32.74%1.28M

-13.06%1.62M

5.61%1.90M

6.15%1.90M

7.89%1.90M

7.91%1.87M

3.45%1.80M

3.41%1.79M

9.04%1.76M

13.29%1.73M

20.93%1.74M

23.91%1.73M

21.70%1.61M

16.20%1.53M

28.62%1.44M

24.73%1.40M

2.79%1.33M

12.20%1.31M

15.62%1.12M

5.76%1.12M

17.47%1.29M

-3.70%1.17M

-21.45%967.00K

-11.16%1.06M

-3.34%1.10M

7.22%1.22M

10.01%1.23M

--1.19M

-2.15%1.14M

-4.94%1.14M

-6.44%1.12M

--1.16M

--1.19M

--1.20M

營業利潤

37.62%-29.61M

48.42%-33.66M

42.72%-38.90M

130.97%15.08M

16.12%-47.47M

-251.23%-65.26M

-54.31%-67.92M

-5.43%-48.69M

-33.98%-56.59M

187.67%43.15M

-107.52%-44.01M

-138.29%-46.18M

-7.93%-42.24M

-40.49%-49.22M

38.83%-21.21M

-97.64%-19.38M

-105.86%-39.13M

-41.03%-35.04M

-226.59%-34.67M

40.28%-9.80M

0.89%-19.01M

-68.06%-24.84M

16.63%-10.62M

-19.96%-16.42M

-34.45%-19.18M

-351.36%-14.78M

-25.38%-12.73M

---13.69M

-21.90%-14.27M

78.41%-3.27M

-853.71%-10.16M

---11.70M

---15.17M

---1.06M

淨非營業利息收入（費用）

利息收入

-48.73%1.64M

-67.78%1.53M

-92.57%2.01M

-48.71%2.52M

-22.14%3.19M

4.45%4.76M

494.33%27.04M

72.80%4.91M

60.00%4.10M

37.25%4.56M

348.72%4.55M

1300.00%2.84M

1510.06%2.56M

1704.89%3.32M

830.28%1.01M

16.00%203.00K

-19.29%159.00K

-93.95%184.00K

-63.05%109.00K

-54.43%175.00K

-69.27%197.00K

275.19%3.04M

-69.40%295.00K

-65.84%384.00K

-45.49%641.00K

-28.51%810.00K

139.21%964.00K

--1.12M

2840.00%1.18M

1298.77%1.13M

550.00%403.00K

--40.00K

--81.00K

--62.00K

利息費用

-22.17%1.01M

-13.21%782.00K

--737.00K

-40.61%1.04M

-41.30%1.30M

-64.53%901.00K

----

-39.69%1.76M

-25.89%2.21M

408.00%2.54M

-1.76%2.74M

385.83%2.92M

326.57%2.99M

-28.57%500.00K

240.00%2.79M

-29.16%600.00K

-18.41%700.00K

16.67%700.00K

-64.61%820.00K

-71.34%847.00K

-18.75%858.00K

-26.56%600.00K

103.07%2.32M

139.85%2.96M

-8.97%1.06M

92.69%817.00K

174.94%1.14M

--1.23M

202.87%1.16M

12.47%424.00K

76.60%415.00K

--383.00K

--377.00K

--235.00K

股權收益

----

-100.00%0.00

-42.22%4.81M

152.62%3.68M

-33.14%7.89M

-80.15%694.00K

322.72%8.32M

-1341.92%-6.99M

558.88%11.81M

-22.02%3.50M

-186.38%-3.74M

105.27%563.00K

93.07%-2.57M

-84.95%4.48M

-91.15%4.33M

---10.69M

---37.14M

--29.78M

--48.86M

----

特殊收入（費用）

99.80%-42.00K

---4.39M

---9.56M

---18.42M

---21.04M

----

其他非經營性收入（費用）

-1.32%-9.47M

-9.86%-9.55M

-22.25%-9.67M

-32.40%-9.65M

-30.07%-9.34M

-40.34%-8.69M

-33.25%-7.91M

-1548.42%-7.29M

---7.18M

---6.19M

---5.94M

---442.00K

----

794.17%1.07M

62.22%-68.00K

----

--120.00K

---180.00K

稅前利潤

49.32%-38.50M

33.16%-46.84M

-16.54%-56.86M

76.01%-11.52M

-30.50%-75.97M

-249.53%-70.09M

-2.83%-48.79M

-25.11%-48.01M

-17.23%-58.21M

235.49%46.87M

-143.46%-47.45M

-63.21%-38.37M

-26.96%-49.66M

9.26%-34.59M

36.94%-19.49M

-282.18%-23.51M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

所得稅

---15.00K

-103.48%-82.00K

--0.00

-325.00%-18.00K

----

-85.10%2.35M

-100.00%0.00

-94.70%8.00K

-100.00%0.00

--15.81M

--1.84M

-93.96%151.00K

--395.00K

--0.00

--2.50M

----

除稅後利潤

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

持續經營利潤

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

歸属于母公司的淨利潤

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

歸屬普通股東的淨利潤

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

基本每股收益

-221.81%-2.94

-509.85%-5.35

-1026.60%-6.70

77.00%-0.14

3.49%-0.91

-272.32%-0.88

26.88%-0.59

7.40%-0.59

-11.13%-0.95

184.08%0.51

-118.45%-0.81

-15.25%-0.64

-1.33%-0.85

26.42%-0.61

44.39%-0.37

-315.25%-0.55

-27.18%-0.84

44.25%-0.82

-244.08%-0.67

-113.35%-0.13

21.71%-0.66

-130.68%-1.48

182.57%0.46

266.06%1.00

-35.54%-0.84

-880.04%-0.64

-25.59%-0.56

---0.60

-14.63%-0.62

90.56%-0.07

-600.06%-0.45

---0.54

---0.69

---0.06

稀釋每股收益

-221.81%-2.94

-509.85%-5.35

-1026.60%-6.70

77.00%-0.14

3.49%-0.91

-272.32%-0.88

26.88%-0.59

7.40%-0.59

-11.13%-0.95

184.08%0.51

-118.45%-0.81

-15.25%-0.64

-1.33%-0.85

26.42%-0.61

44.39%-0.37

-315.25%-0.55

-27.18%-0.84

44.25%-0.82

-247.94%-0.67

-114.19%-0.13

21.71%-0.66

-130.68%-1.48

180.41%0.45

256.25%0.94

-35.54%-0.84

-880.04%-0.64

-25.59%-0.56

---0.60

-14.63%-0.62

90.56%-0.07

-600.06%-0.45

---0.54

---0.69

---0.06

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Sutro Biopharma Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 STRO 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Sutro Biopharma Inc 財年末的營收是多少？



Sutro Biopharma Inc 2025 財年營收為 102.48M，高於上一財年的 62.04M。

Sutro Biopharma Inc 最近一個季度的營收是多少？



Sutro Biopharma Inc 最近一個季度的營收為 14.52M，同比增長 -16.53%。

Sutro Biopharma Inc 全年的淨利潤是多少？



Sutro Biopharma Inc 2025 財年淨利潤為 -191.09M。

Sutro Biopharma Inc 上一季度的淨利潤是多少？



Sutro Biopharma Inc 最近一個季度的淨利潤為 -38.48M。

Sutro Biopharma Inc 年度營業利潤是多少？



Sutro Biopharma Inc 2025 財年的營業利潤為 -104.95M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。